HEADER MEMBRANE PROTEIN 15-JUN-23 8JR1 TITLE CRYO-EM STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS ATP SYNTHASE FO IN TITLE 2 COMPLEX WITH TBAJ-587 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ATP SYNTHASE SUBUNIT C; COMPND 3 CHAIN: 1, 2, 3, 4, 5, 6, 7, 8, 9; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: ATP SYNTHASE SUBUNIT A; COMPND 7 CHAIN: a; COMPND 8 SYNONYM: ATP SYNTHASE F0 SECTOR SUBUNIT A,F-ATPASE SUBUNIT 6; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS; SOURCE 3 ORGANISM_TAXID: 1773; SOURCE 4 GENE: ATPE; SOURCE 5 EXPRESSION_SYSTEM: MYCOLICIBACTERIUM SMEGMATIS; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 1772; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS; SOURCE 9 ORGANISM_TAXID: 1773; SOURCE 10 GENE: ATPB, ERS007657_00358, ERS007661_00092, ERS007663_00105, SOURCE 11 ERS007665_00910, ERS007670_00031, ERS007679_03316, ERS007681_03471, SOURCE 12 ERS007688_02939, ERS007703_00159, ERS007720_03212, ERS007722_00190, SOURCE 13 ERS007739_02359, ERS007741_03568, ERS024276_02583, ERS027646_02991, SOURCE 14 ERS027659_00329, ERS027661_00021, SAMEA2683035_01568; SOURCE 15 EXPRESSION_SYSTEM: MYCOLICIBACTERIUM SMEGMATIS; SOURCE 16 EXPRESSION_SYSTEM_TAXID: 1772 KEYWDS ATP SYNTHASE, MYCOBACTERIUM TUBERCULOSIS, CRYO-EM, MEMBRANE PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR Y.ZHANG,Y.LAI,F.LIU,Z.RAO,H.GONG REVDAT 1 01-MAY-24 8JR1 0 JRNL AUTH Y.ZHANG,Y.LAI,F.LIU,Z.RAO,H.GONG JRNL TITL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS ATP SYNTHASE JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 3.17 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.170 REMARK 3 NUMBER OF PARTICLES : 81528 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8JR1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 21-JUN-23. REMARK 100 THE DEPOSITION ID IS D_1300038656. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : MYCOBACTERIUM TUBERCULOSIS ATP REMARK 245 SYNTHASE REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : FEI FALCON IV (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1200.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2400.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DECAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: 1, 2, 3, 4, 5, 6, 7, 8, 9, a REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET a 1 REMARK 465 THR a 2 REMARK 465 GLU a 3 REMARK 465 THR a 4 REMARK 465 ILE a 5 REMARK 465 LEU a 6 REMARK 465 ALA a 7 REMARK 465 ALA a 8 REMARK 465 THR a 112 REMARK 465 ASP a 113 REMARK 465 LYS a 114 REMARK 465 HIS a 115 REMARK 465 GLY a 116 REMARK 465 HIS a 117 REMARK 465 THR a 118 REMARK 465 ILE a 153 REMARK 465 VAL a 154 REMARK 465 GLY a 155 REMARK 465 HIS a 156 REMARK 465 PRO a 157 REMARK 465 ILE a 158 REMARK 465 LYS a 159 REMARK 465 LEU a 160 REMARK 465 LEU a 161 REMARK 465 LYS a 162 REMARK 465 GLU a 246 REMARK 465 GLU a 247 REMARK 465 GLU a 248 REMARK 465 HIS a 249 REMARK 465 HIS a 250 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA 2 77 43.02 -141.09 REMARK 500 THR 2 78 99.15 -31.83 REMARK 500 PRO 3 43 0.82 -60.66 REMARK 500 THR 5 78 73.79 44.82 REMARK 500 THR 6 78 74.90 51.80 REMARK 500 ALA 7 77 46.32 -146.64 REMARK 500 THR 7 78 117.97 -38.84 REMARK 500 THR 8 78 74.86 48.78 REMARK 500 LEU a 21 50.93 -151.45 REMARK 500 THR a 29 -60.09 66.41 REMARK 500 SER a 53 -58.95 -148.91 REMARK 500 LEU a 122 39.87 -74.62 REMARK 500 ALA a 127 21.77 -74.34 REMARK 500 ARG a 151 -60.85 -149.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-36590 RELATED DB: EMDB REMARK 900 CRYO-EM STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS ATP SYNTHASE FO IN REMARK 900 COMPLEX WITH TBAJ-587 DBREF1 8JR1 1 1 81 UNP A0A045H4W8_MYCTX DBREF2 8JR1 1 A0A045H4W8 1 81 DBREF1 8JR1 2 1 81 UNP A0A045H4W8_MYCTX DBREF2 8JR1 2 A0A045H4W8 1 81 DBREF1 8JR1 3 1 81 UNP A0A045H4W8_MYCTX DBREF2 8JR1 3 A0A045H4W8 1 81 DBREF1 8JR1 4 1 81 UNP A0A045H4W8_MYCTX DBREF2 8JR1 4 A0A045H4W8 1 81 DBREF1 8JR1 5 1 81 UNP A0A045H4W8_MYCTX DBREF2 8JR1 5 A0A045H4W8 1 81 DBREF1 8JR1 6 1 81 UNP A0A045H4W8_MYCTX DBREF2 8JR1 6 A0A045H4W8 1 81 DBREF1 8JR1 7 1 81 UNP A0A045H4W8_MYCTX DBREF2 8JR1 7 A0A045H4W8 1 81 DBREF1 8JR1 8 1 81 UNP A0A045H4W8_MYCTX DBREF2 8JR1 8 A0A045H4W8 1 81 DBREF1 8JR1 9 1 81 UNP A0A045H4W8_MYCTX DBREF2 8JR1 9 A0A045H4W8 1 81 DBREF1 8JR1 a 1 250 UNP A0A045J1C5_MYCTX DBREF2 8JR1 a A0A045J1C5 1 250 SEQRES 1 1 81 MET ASP PRO THR ILE ALA ALA GLY ALA LEU ILE GLY GLY SEQRES 2 1 81 GLY LEU ILE MET ALA GLY GLY ALA ILE GLY ALA GLY ILE SEQRES 3 1 81 GLY ASP GLY VAL ALA GLY ASN ALA LEU ILE SER GLY VAL SEQRES 4 1 81 ALA ARG GLN PRO GLU ALA GLN GLY ARG LEU PHE THR PRO SEQRES 5 1 81 PHE PHE ILE THR VAL GLY LEU VAL GLU ALA ALA TYR PHE SEQRES 6 1 81 ILE ASN LEU ALA PHE MET ALA LEU PHE VAL PHE ALA THR SEQRES 7 1 81 PRO VAL LYS SEQRES 1 2 81 MET ASP PRO THR ILE ALA ALA GLY ALA LEU ILE GLY GLY SEQRES 2 2 81 GLY LEU ILE MET ALA GLY GLY ALA ILE GLY ALA GLY ILE SEQRES 3 2 81 GLY ASP GLY VAL ALA GLY ASN ALA LEU ILE SER GLY VAL SEQRES 4 2 81 ALA ARG GLN PRO GLU ALA GLN GLY ARG LEU PHE THR PRO SEQRES 5 2 81 PHE PHE ILE THR VAL GLY LEU VAL GLU ALA ALA TYR PHE SEQRES 6 2 81 ILE ASN LEU ALA PHE MET ALA LEU PHE VAL PHE ALA THR SEQRES 7 2 81 PRO VAL LYS SEQRES 1 3 81 MET ASP PRO THR ILE ALA ALA GLY ALA LEU ILE GLY GLY SEQRES 2 3 81 GLY LEU ILE MET ALA GLY GLY ALA ILE GLY ALA GLY ILE SEQRES 3 3 81 GLY ASP GLY VAL ALA GLY ASN ALA LEU ILE SER GLY VAL SEQRES 4 3 81 ALA ARG GLN PRO GLU ALA GLN GLY ARG LEU PHE THR PRO SEQRES 5 3 81 PHE PHE ILE THR VAL GLY LEU VAL GLU ALA ALA TYR PHE SEQRES 6 3 81 ILE ASN LEU ALA PHE MET ALA LEU PHE VAL PHE ALA THR SEQRES 7 3 81 PRO VAL LYS SEQRES 1 4 81 MET ASP PRO THR ILE ALA ALA GLY ALA LEU ILE GLY GLY SEQRES 2 4 81 GLY LEU ILE MET ALA GLY GLY ALA ILE GLY ALA GLY ILE SEQRES 3 4 81 GLY ASP GLY VAL ALA GLY ASN ALA LEU ILE SER GLY VAL SEQRES 4 4 81 ALA ARG GLN PRO GLU ALA GLN GLY ARG LEU PHE THR PRO SEQRES 5 4 81 PHE PHE ILE THR VAL GLY LEU VAL GLU ALA ALA TYR PHE SEQRES 6 4 81 ILE ASN LEU ALA PHE MET ALA LEU PHE VAL PHE ALA THR SEQRES 7 4 81 PRO VAL LYS SEQRES 1 5 81 MET ASP PRO THR ILE ALA ALA GLY ALA LEU ILE GLY GLY SEQRES 2 5 81 GLY LEU ILE MET ALA GLY GLY ALA ILE GLY ALA GLY ILE SEQRES 3 5 81 GLY ASP GLY VAL ALA GLY ASN ALA LEU ILE SER GLY VAL SEQRES 4 5 81 ALA ARG GLN PRO GLU ALA GLN GLY ARG LEU PHE THR PRO SEQRES 5 5 81 PHE PHE ILE THR VAL GLY LEU VAL GLU ALA ALA TYR PHE SEQRES 6 5 81 ILE ASN LEU ALA PHE MET ALA LEU PHE VAL PHE ALA THR SEQRES 7 5 81 PRO VAL LYS SEQRES 1 6 81 MET ASP PRO THR ILE ALA ALA GLY ALA LEU ILE GLY GLY SEQRES 2 6 81 GLY LEU ILE MET ALA GLY GLY ALA ILE GLY ALA GLY ILE SEQRES 3 6 81 GLY ASP GLY VAL ALA GLY ASN ALA LEU ILE SER GLY VAL SEQRES 4 6 81 ALA ARG GLN PRO GLU ALA GLN GLY ARG LEU PHE THR PRO SEQRES 5 6 81 PHE PHE ILE THR VAL GLY LEU VAL GLU ALA ALA TYR PHE SEQRES 6 6 81 ILE ASN LEU ALA PHE MET ALA LEU PHE VAL PHE ALA THR SEQRES 7 6 81 PRO VAL LYS SEQRES 1 7 81 MET ASP PRO THR ILE ALA ALA GLY ALA LEU ILE GLY GLY SEQRES 2 7 81 GLY LEU ILE MET ALA GLY GLY ALA ILE GLY ALA GLY ILE SEQRES 3 7 81 GLY ASP GLY VAL ALA GLY ASN ALA LEU ILE SER GLY VAL SEQRES 4 7 81 ALA ARG GLN PRO GLU ALA GLN GLY ARG LEU PHE THR PRO SEQRES 5 7 81 PHE PHE ILE THR VAL GLY LEU VAL GLU ALA ALA TYR PHE SEQRES 6 7 81 ILE ASN LEU ALA PHE MET ALA LEU PHE VAL PHE ALA THR SEQRES 7 7 81 PRO VAL LYS SEQRES 1 8 81 MET ASP PRO THR ILE ALA ALA GLY ALA LEU ILE GLY GLY SEQRES 2 8 81 GLY LEU ILE MET ALA GLY GLY ALA ILE GLY ALA GLY ILE SEQRES 3 8 81 GLY ASP GLY VAL ALA GLY ASN ALA LEU ILE SER GLY VAL SEQRES 4 8 81 ALA ARG GLN PRO GLU ALA GLN GLY ARG LEU PHE THR PRO SEQRES 5 8 81 PHE PHE ILE THR VAL GLY LEU VAL GLU ALA ALA TYR PHE SEQRES 6 8 81 ILE ASN LEU ALA PHE MET ALA LEU PHE VAL PHE ALA THR SEQRES 7 8 81 PRO VAL LYS SEQRES 1 9 81 MET ASP PRO THR ILE ALA ALA GLY ALA LEU ILE GLY GLY SEQRES 2 9 81 GLY LEU ILE MET ALA GLY GLY ALA ILE GLY ALA GLY ILE SEQRES 3 9 81 GLY ASP GLY VAL ALA GLY ASN ALA LEU ILE SER GLY VAL SEQRES 4 9 81 ALA ARG GLN PRO GLU ALA GLN GLY ARG LEU PHE THR PRO SEQRES 5 9 81 PHE PHE ILE THR VAL GLY LEU VAL GLU ALA ALA TYR PHE SEQRES 6 9 81 ILE ASN LEU ALA PHE MET ALA LEU PHE VAL PHE ALA THR SEQRES 7 9 81 PRO VAL LYS SEQRES 1 a 250 MET THR GLU THR ILE LEU ALA ALA GLN ILE GLU VAL GLY SEQRES 2 a 250 GLU HIS HIS THR ALA THR TRP LEU GLY MET THR VAL ASN SEQRES 3 a 250 THR ASP THR VAL LEU SER THR ALA ILE ALA GLY LEU ILE SEQRES 4 a 250 VAL ILE ALA LEU ALA PHE TYR LEU ARG ALA LYS VAL THR SEQRES 5 a 250 SER THR ASP VAL PRO GLY GLY VAL GLN LEU PHE PHE GLU SEQRES 6 a 250 ALA ILE THR ILE GLN MET ARG ASN GLN VAL GLU SER ALA SEQRES 7 a 250 ILE GLY MET ARG ILE ALA PRO PHE VAL LEU PRO LEU ALA SEQRES 8 a 250 VAL THR ILE PHE VAL PHE ILE LEU ILE SER ASN TRP LEU SEQRES 9 a 250 ALA VAL LEU PRO VAL GLN TYR THR ASP LYS HIS GLY HIS SEQRES 10 a 250 THR THR GLU LEU LEU LYS SER ALA ALA ALA ASP ILE ASN SEQRES 11 a 250 TYR VAL LEU ALA LEU ALA LEU PHE VAL PHE VAL CYS TYR SEQRES 12 a 250 HIS THR ALA GLY ILE TRP ARG ARG GLY ILE VAL GLY HIS SEQRES 13 a 250 PRO ILE LYS LEU LEU LYS GLY HIS VAL THR LEU LEU ALA SEQRES 14 a 250 PRO ILE ASN LEU VAL GLU GLU VAL ALA LYS PRO ILE SER SEQRES 15 a 250 LEU SER LEU ARG LEU PHE GLY ASN ILE PHE ALA GLY GLY SEQRES 16 a 250 ILE LEU VAL ALA LEU ILE ALA LEU PHE PRO PRO TYR ILE SEQRES 17 a 250 MET TRP ALA PRO ASN ALA ILE TRP LYS ALA PHE ASP LEU SEQRES 18 a 250 PHE VAL GLY ALA ILE GLN ALA PHE ILE PHE ALA LEU LEU SEQRES 19 a 250 THR ILE LEU TYR PHE SER GLN ALA MET GLU LEU GLU GLU SEQRES 20 a 250 GLU HIS HIS HET UTI 4 600 40 HET UTI 5 600 40 HET UTI 6 600 40 HET UTI 7 600 40 HET UTI 8 600 40 HET UTI 9 600 40 HET UTI a 600 40 HETNAM UTI (1~{S},2~{S})-1-(6-BROMANYL-2-METHOXY-QUINOLIN-3-YL)-2- HETNAM 2 UTI (2,6-DIMETHOXYPYRIDIN-4-YL)-4-(DIMETHYLAMINO)-1-(2- HETNAM 3 UTI FLUORANYL-3-METHOXY-PHENYL)BUTAN-2-OL HETSYN UTI TBAJ-587 FORMUL 11 UTI 7(C30 H33 BR F N3 O5) HELIX 1 AA1 MET 1 1 GLN 1 42 1 42 HELIX 2 AA2 ALA 1 45 PHE 1 76 1 32 HELIX 3 AA3 ASP 2 2 GLN 2 42 1 41 HELIX 4 AA4 ALA 2 45 ALA 2 77 1 33 HELIX 5 AA5 ASP 3 2 GLN 3 42 1 41 HELIX 6 AA6 ALA 3 45 PHE 3 76 1 32 HELIX 7 AA7 ASP 4 2 GLN 4 42 1 41 HELIX 8 AA8 ALA 4 45 ALA 4 77 1 33 HELIX 9 AA9 ASP 5 2 GLN 5 42 1 41 HELIX 10 AB1 ALA 5 45 THR 5 78 1 34 HELIX 11 AB2 ASP 6 2 GLN 6 42 1 41 HELIX 12 AB3 ALA 6 45 PHE 6 76 1 32 HELIX 13 AB4 ASP 7 2 GLN 7 42 1 41 HELIX 14 AB5 ALA 7 45 ALA 7 77 1 33 HELIX 15 AB6 ASP 8 2 GLN 8 42 1 41 HELIX 16 AB7 ALA 8 45 THR 8 78 1 34 HELIX 17 AB8 ASP 9 2 GLN 9 42 1 41 HELIX 18 AB9 ALA 9 45 PHE 9 76 1 32 HELIX 19 AC1 THR a 27 VAL a 51 1 25 HELIX 20 AC2 GLY a 58 ILE a 79 1 22 HELIX 21 AC3 PHE a 86 LEU a 104 1 19 HELIX 22 AC4 ALA a 105 LEU a 107 5 3 HELIX 23 AC5 ASP a 128 ARG a 151 1 24 HELIX 24 AC6 VAL a 165 LEU a 167 5 3 HELIX 25 AC7 LEU a 168 ILE a 201 1 34 HELIX 26 AC8 ALA a 202 PHE a 204 5 3 HELIX 27 AC9 MET a 209 MET a 243 1 35 SHEET 1 AA1 2 THR a 17 THR a 19 0 SHEET 2 AA1 2 THR a 24 ASN a 26 -1 O VAL a 25 N ALA a 18 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000